Effect of aflibercept on proliferative vitreoretinopathy: Proteomic analysis in an experimental animal model

被引:5
|
作者
Uslubas, Isil [1 ,3 ]
Kanli, Aylin [2 ]
Kasap, Murat [2 ]
Akpinar, Gurler [2 ]
Karabas, Levent [1 ]
机构
[1] Kocaeli Univ, Dept Ophthalmol, Sch Med, Kocaeli, Turkey
[2] Kocaeli Univ, Dept Med Biol, Sch Med, Kocaeli, Turkey
[3] Golcuk Necati Celik State Hosp, TR-41650 Kocaeli, Turkey
关键词
Proliferative vitreoretinopathy; Aflibercept; Dispase; Proteomic; Animal model;
D O I
10.1016/j.exer.2020.108425
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study was to monitor inflammatory, proliferative and progressive effects of proliferative vitreoretinopathy (PVR) and aflibercept treatment in dispase induced PVR rat model by proteomic analysis. Material and methods: A total of 35 male Long Evans pigmented rats were divided into three groups, namely, PVR (dispase+saline), PVR+aflibercept (dispase+aflibercept) and control. The PVR group received 2 mu l of 0.03 IU/mu l dispase and 2 mu l saline, the PVR+aflibercept group received 2 mu l of 0.03 IU/mu l and 2 mu l of 40 mg/ml aflibercept at the first day of the experiment. At the end of the 6th week all retina and vitreous specimens were collected by evisceration and transferred to the proteomics laboratory for analysis. Proteomic analysis by 2D gel electrophoresis coupled with MALDI-TOF/TOF was performed. Results: In the PVR and PVR+aflibercept group 16 different proteins that were identified to be differentially regulated in comparison to the control group. In the PVR+aflibercept group, ENO1, ENO2, LDH-B, PEBP-1 and GS levels were higher than the PVR group. In addition, the association of proteins such as UCHL, PEBP1, PDHB and ENO1 with PVR has been demonstrated for the first time. Conclusion: STRING analysis elucidated the functional protein-protein interaction among the differentially regulated proteins and highlighted that those proteins mainly played roles in carbon and nucleotide metabolisms. Functional analysis of the differentially regulated proteins indicated the presence of inflammation, gliosis and retinal damage in the PVR group. Aflibercept treatment had pronounced effect on prevention of inflammation and retinal damage while causing a slight increase in gliosis. However, aflibercept treatment was not effective enough to normalize the levels of differentially regulated proteins of the PVR group. Therefore, we predict that the treatment dose of aflibercept used in this study was below of its ideal concentration and should be increased in the future studies. The differential regulation of these structural proteins in this study should shed some light to the mechanism of glial wound formation in the retina and guide future treatment modalities.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] A Porcine Model of Proliferative Vitreoretinopathy
    Bansal, A. S.
    Grossniklaus, H. E.
    Olsen, T. W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [12] The impact of octreotide in experimental proliferative vitreoretinopathy
    Evren, Ozge
    Turgut, Burak
    Celiker, Ulku
    Ates, Kadir
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2013, 61 (03) : 109 - 114
  • [13] THE EFFECT OF COMBINED DAUNORUBICIN AND TRIAMCINOLONE ACETONIDE TREATMENT ON A REFINED EXPERIMENTAL-MODEL OF PROLIFERATIVE VITREORETINOPATHY
    CHEN, EP
    STEINHORST, UH
    SAMSA, GP
    SALOUPIS, PT
    HATCHELL, DL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (07) : 2160 - 2164
  • [14] Inflammation measurement and immunocharacterization of cell proliferation in an experimental model of proliferative vitreoretinopathy
    Baudouin, C
    Khosravi, E
    Pisella, PJ
    Ettaiche, M
    Elena, PP
    OPHTHALMIC RESEARCH, 1998, 30 (06) : 340 - 350
  • [15] Experimental model for proliferative vitreoretinopathy by intravitreal dispase: Limited by Zonulolysis and cataract
    Kralinger, MT
    Kieselbach, GF
    Voigt, M
    Hayden, B
    Hernandez, E
    Fernandez, V
    Pare, JM
    OPHTHALMOLOGICA, 2006, 220 (04) : 211 - 216
  • [16] Porcine model of proliferative vitreoretinopathy with platelets
    GarciaLayana, A
    Pastor, JC
    Saornil, MA
    Gonzalez, G
    CURRENT EYE RESEARCH, 1997, 16 (06) : 556 - 563
  • [17] INHIBITION OF EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY IN RABBITS BY SURAMIN
    DESOUZA, OF
    SAKAMOTO, T
    KIMURA, H
    KODA, RP
    GABRIELIAN, K
    SPEE, C
    RYAN, SJ
    OPHTHALMOLOGICA, 1995, 209 (04) : 212 - 216
  • [18] Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy
    Amarnani, Dhanesh
    Machuca-Parra, Arturo Israel
    Wong, Lindsay L.
    Marko, Christina K.
    Stefater, James A.
    Stryjewski, Tomasz P.
    Eliott, Dean
    Arboleda-Velasquez, Joseph E.
    Kim, Leo A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (10) : 3940 - 3949
  • [19] Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy
    Kuo, Hsi-Kung
    Chen, Yi-Hao
    Kuo, Yu-Hsia
    Ke, Mu-Chan
    Tseng, Ya-chi
    Wu, Pei-Chang
    CURRENT EYE RESEARCH, 2018, 43 (03) : 333 - 339
  • [20] Experimental Modeling of Proliferative Vitreoretinopathy. An Experimental Morphological Study
    Khoroshilova-Maslova, I. P.
    Leparskaya, N. L.
    Nabieva, M. M.
    Andreeva, L. D.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 159 (01) : 100 - 102